Eric Flachbart is an experienced executive in the medical devices and technology sectors, currently serving as the Vice President of Regulatory Affairs at Byonyks since January 2022. Flachbart has held various leadership roles, including President at Infusion Analytics LLC and IVmetrix LLC since November 2017 and President of Numia Medical Technology, LLC from 2005 to October 2016. Previously, Flachbart was the Chief Technology Officer at Byonyks Pvt LTD from September 2018 to January 2021 and held the position of Vice President at Harvard Clinical Technology from 1993 to 2005. Early in the career, Flachbart worked as a Reliability Engineer at Bard MedSystems and Textron Defense. Educational achievements include a degree from Merrimack College.
This person is not in any teams
This person is not in any offices